|
Cardiovascular Intervention
Contributing journals to this collection:
JAMA & Archives Journals
Citations 221-230 of 842 total displayed.
- Original Investigations
Management Patterns in Relation to Risk Stratification Among Patients With NonST Elevation Acute Coronary Syndromes
- Andrew T. Yan; Raymond T. Yan; Mary Tan; Anthony Fung; Eric A. Cohen; David H. Fitchett; Anatoly Langer; Shaun G. Goodman; for the Canadian Acute Coronary Syndromes 1 and 2 Registry Investigators
Arch Intern Med 2007; 167: 1009-1016.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
New Drug-Eluting Stents Under Study
- Mike Mitka
JAMA 2007; 297: 2064-2067.
[Extract]
[Full text]
[PDF]
- Original Investigations
Outcomes of Myocardial Infarction in Hospitals With Percutaneous Coronary Intervention Facilities
- Jose Labarere; Loic Belle; Magali Fourny; Nathalie Genès; Jean-Marc Lablanche; Didier Blanchard; Jean-Pierre Cambou; Nicolas Danchin; for the Unité de Soins Intensifs Coronaires 2000 Investigators
Arch Intern Med 2007; 167: 913-920.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
Cardiologists Get Wake-up Call on Stents
- Mike Mitka
JAMA 2007; 297: 1967-1968.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial
- Paul Erne; Andreas W. Schoenenberger; Dieter Burckhardt; Michel Zuber; Wolfgang Kiowski; Peter T. Buser; Paul Dubach; Therese J. Resink; Matthias Pfisterer
JAMA 2007; 297: 1985-1991.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
- Nirat Beohar; Charles J. Davidson; Kevin E. Kip; Lynne Goodreau; Helen Aslanidou Vlachos; Sheridan N. Meyers; Keith H. Benzuly; James D. Flaherty; Mark J. Ricciardi; Charles L. Bennett; David O. Williams
JAMA 2007; 297: 1992-2000.
[Abstract]
[Full text]
[PDF]
[ JAMA News Video ]
- Original Contributions
Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
- Htut K. Win; Angel E. Caldera; Kelly Maresh; John Lopez; Charanjit S. Rihal; Manish A. Parikh; Juan F. Granada; Sachin Marulkar; Deborah Nassif; David J. Cohen; Neal S. Kleiman; for the EVENT Registry Investigators
JAMA 2007; 297: 2001-2009.
[Abstract]
[Full text]
[PDF]
- Editorials
The Enigma of Drug-Eluting Stents: Hope, Hype, Humility, and Advancing Patient Care
- Robert A. Harrington; E. Magnus Ohman
JAMA 2007; 297: 2028-2030.
[Extract]
[Full text]
[PDF]
- Letters
Pexelizumab and the APEX AMI TrialReply
- John W. Eikelboom; Martin ODonnell
JAMA 2007; 297: 1881-b-1882-b.
[Extract]
[Full text]
[PDF]
- Letters
Pexelizumab and the APEX AMI Trial
- Paul W. Armstrong; Christopher B. Granger
JAMA 2007; 297: 1881-a.
[Extract]
[Full text]
[PDF]
|
Advertisement


|
|
|